DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xd82k3/cardiovascular) has announced the addition of the "Cardiovascular Disease Diagnostics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Cardiovascular Disease Diagnostics in US$ Million by the following Two Broad Segments: In Vitro Diagnostics, and In Vivo Diagnostics. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America.
The report profiles 70 companies including many key and niche players worldwide such as AccuTech, LLC, Abbott Diagnostics, Alere Inc., Cholestech Corp., Ani Biotech Oy, Axis-Shield PoC, Beckman Coulter, Inc., biomérieux, Cambridge Heart, Inc., GE HealthCare, Home Access Health Corporation, LifeSign LLC, Liposcience, Inc., Nanosphere, Inc., Ortho-Clinical Diagnostics, Inc., Philips Healthcare, Polymer Technology Systems, Inc., Response Biomedical Corp., Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., St. Jude Medical, Inc., and EP MedSystems.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. INDUSTRY OVERVIEW
2. IN-VIVO DIAGNOSTICS
3. IN-VITRO DIAGNOSTICS
4. CVD - CAUSE AND RISK FACTORS
5. CARDIOVASCULAR DISEASE AND CONDITIONS
6. DIAGNOSTIC TESTS FOR CARDIOVASCULAR DISEASES
7. PRODUCT LAUNCHES AND DEVELOPMENTS
8. PRODUCT LAUNCHES AND DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER
9. RECENT INDUSTRY ACTIVITY
10. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER
11. FOCUS ON SELECT GLOBAL PLAYERS
12. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. THE MIDDLE EAST
7. LATIN AMERICA
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 70 (including Divisions/Subsidiaries - 82)
Region/Country Players
- The United States 57
- Canada 3
- Japan 4
- Europe 15
- France 1
- Germany 1
- The United Kingdom 5
- Italy 3
- Rest of Europe 5
- Asia-Pacific (Excluding Japan) 1
- Middle-East 2
For more information visit http://www.researchandmarkets.com/research/xd82k3/cardiovascular